Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
Milica Radosavljević, Dubravka Švob Štrac, Jasna Jančić, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1095-1095
Open Access | Times Cited: 22

Showing 22 citing articles:

Deciphering Depression: Epigenetic Mechanisms and Treatment Strategies
Alaa A. A. Aljabali, Almuthanna K. Alkaraki, Omar Gammoh, et al.
Biology (2024) Vol. 13, Iss. 8, pp. 638-638
Open Access | Times Cited: 8
Of Mice and Men: The Inter-individual Variability of the Brain's Response to Drugs
Wolfgang Löscher
eNeuro (2024) Vol. 11, Iss. 2, pp. ENEURO.0518-23.2024
Open Access | Times Cited: 4
Brain region–specific roles of brain-derived neurotrophic factor in social stress–induced depressive-like behavior
Man Yong Han, Deyang Zeng, Wei Tan, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 1, pp. 159-173
Open Access | Times Cited: 4
Modern Experience in Pharmacotherapy of Irritable Bowel Syndrome in Children
А. И. Хавкин, K. M. Nikolaychuk, A. S. Veremenko, et al.
Педиатрическая фармакология (2025) Vol. 21, Iss. 6, pp. 539-550
Open Access
Cyclodextrin-Based Drug Delivery Systems for Depression: Improving Antidepressant Bioavailability and Targeted Central Nervous System Delivery
Renata Maria Văruț, Alin Iulian Silviu Popescu, Simina Găman, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 355-355
Open Access
Comprehensive pharmacogenomics profiling of the Serbian population
Marina Jelovac, Djordje Pavlovic, Biljana Stanković, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
High-performance liquid chromatography–tandem mass spectrometry for simultaneous determination of 23 antidepressants and active metabolites in human serum and its application in therapeutic drug monitoring
Jinglong Wang, Junjie Wang, Chenxiao Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Aging‐Driven Blood–Brain Barrier Dysfunction and Its Impact on CNS Cancer Susceptibility: A Comprehensive Narrative Review
Quang Ngoc La, Aurangzaib Quadir Baloch, David F. Lo
Aging and Cancer (2025)
Open Access
Competitive Endogenous RNA Network Involving Immune Subgroups, Infiltration, and lncRNAs in Prostate Cancer
Wenkang Niu, Tingting Zhang, Lei Ma
Genes (2025) Vol. 16, Iss. 5, pp. 527-527
Open Access
Endoplasmic Reticulum Stress in Neurodegenerative Diseases
Syed-Abdul-Moiz Hasan, Antonisamy William James, Farzeen M. Fazili, et al.
Journal of dementia and Alzheimer's disease (2024) Vol. 1, Iss. 2, pp. 87-97
Open Access | Times Cited: 3
Systems biology approaches to identify potential targets and inhibitors of the intestinal microbiota to treat depression
Fei Teng, Zhongwen Lu, Fei Gao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
Bradley Roberts, Zahra Cooper, Stephanie Lu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Serious adverse drug events associated with psychotropic treatment of bipolar or schizoaffective disorder: a 17-year follow-up on the LiSIE retrospective cohort study
Petra Truedson, Michael Ott, Lisa Wahlström, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Decoding the genetic landscape of autism: A comprehensive review
Mohammed Al‐Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy, et al.
World Journal of Clinical Pediatrics (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Therapeutic drug monitoring, liquid biopsies or pharmacogenomics for prediction of human drug metabolism and response
Magnus Ingelman‐Sundberg, Espen Molden
British Journal of Clinical Pharmacology (2024)
Open Access | Times Cited: 1
Sex-controlled differences in sertraline and citalopram efficacies in major depressive disorder: a randomized, double-blind trial
Ahmad Shamabadi, Hanie Karimi, Mohammad Ali Fallahzadeh, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 1
Drug–Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance Database
Carmen Maximiliana Dobrea, Adina Frum, Anca Butucă, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1278-1278
Open Access | Times Cited: 1
Therapeutical Approach to Arterial Hypertension - Current State of the Art
Milica Radosavljević, Danijela Vučević, Janko Samardžić, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 29, pp. 4602-4620
Closed Access
TRATAMIENTO DE LA ANSIEDAD Y DEPRESIÓN EN PEDIATRÍA: REVISIÓN DE AVANCES RECIENTES.
Zully Stefania Cedeño Roballino, Miguel Anderson Tayupanta Alban, Jazmín Natalie Gallegos Polo, et al.
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 3, pp. 2944-2955
Open Access
Pharmacogenetics in IBS: update and impact of GWAS studies in drug targets and metabolism
Michael Camilleri, Kara Jencks
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 5, pp. 319-332
Closed Access
Biomarker-Guided Tailored Therapy in Major Depression
Giampaolo Perna, Alessandro Spiti, Tatiana Torti, et al.
Advances in experimental medicine and biology (2024), pp. 379-400
Closed Access
Genetic Basis of Stress-Related Neuropsychiatric Disorders
Dubravka Švob Štrac
Genes (2024) Vol. 15, Iss. 10, pp. 1274-1274
Open Access
Selected Genetic Polymorphisms in Psychiatry
Aneta Bednářová, Ivan Dóci, Slávka Dubinská, et al.
(2024), pp. 1-28
Closed Access
The psychological impact of non-responsiveness to antidepressants on patients with depression and the role of pharmacogenomics-based drug therapy
Chinonyelum Emmanuel Agbo, Uzochukwu E. Chima, Chukwuemeka Augustine Nwachuya, et al.
American Journal of Pharmacotherapy and Pharmaceutical Sciences (2023) Vol. 2, pp. 14-14
Closed Access
Page 1

Scroll to top